212 related articles for article (PubMed ID: 18633486)
1. Binding of a dinuclear ruthenium(ii) complex to the TAR region of the HIV-AIDS viral RNA.
Buck DP; Spillane CB; Collins JG; Keene FR
Mol Biosyst; 2008 Aug; 4(8):851-4. PubMed ID: 18633486
[TBL] [Abstract][Full Text] [Related]
2. Base flexibility in HIV-2 TAR RNA mapped by solution (15)N, (13)C NMR relaxation.
Dayie KT; Brodsky AS; Williamson JR
J Mol Biol; 2002 Mar; 317(2):263-78. PubMed ID: 11902842
[TBL] [Abstract][Full Text] [Related]
3. Roles of RNA:DNA hybrid stability, RNA structure, and active site conformation in pausing by human RNA polymerase II.
Palangat M; Landick R
J Mol Biol; 2001 Aug; 311(2):265-82. PubMed ID: 11478860
[TBL] [Abstract][Full Text] [Related]
4. Dynamic ensemble view of the conformational landscape of HIV-1 TAR RNA and allosteric recognition.
Lu J; Kadakkuzha BM; Zhao L; Fan M; Qi X; Xia T
Biochemistry; 2011 Jun; 50(22):5042-57. PubMed ID: 21553929
[TBL] [Abstract][Full Text] [Related]
5. A molecular mechanics investigation of RNA complexes. I. Ethidium intercalation in an HIV-1 TAR RNA sequence with an unpaired adenosine.
Yao S; Wilson WD
J Biomol Struct Dyn; 1992 Oct; 10(2):367-87. PubMed ID: 1466814
[TBL] [Abstract][Full Text] [Related]
6. Stability of the TAR RNA and its complex with arginine.
Sugimoto N; Ohmichi T; Tanaka A; Matsumura A; Sasaki M
Nucleic Acids Symp Ser; 1993; (29):167-8. PubMed ID: 8247753
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence correlation spectroscopy at single molecule level on the Tat-TAR complex and its inhibitors.
Nandi CK; Parui PP; Brutschy B; Scheffer U; Göbel M
Biopolymers; 2008 Jan; 89(1):17-25. PubMed ID: 17764074
[TBL] [Abstract][Full Text] [Related]
8. An Arg/Lys-rich core peptide mimics TRBP binding to the HIV-1 TAR RNA upper-stem/loop.
Erard M; Barker DG; Amalric F; Jeang KT; Gatignol A
J Mol Biol; 1998 Jun; 279(5):1085-99. PubMed ID: 9642086
[TBL] [Abstract][Full Text] [Related]
9. Hexitol nucleic acid-containing aptamers are efficient ligands of HIV-1 TAR RNA.
Kolb G; Reigadas S; Boiziau C; van Aerschot A; Arzumanov A; Gait MJ; Herdewijn P; Toulmé JJ
Biochemistry; 2005 Mar; 44(8):2926-33. PubMed ID: 15723535
[TBL] [Abstract][Full Text] [Related]
10. TAR-RNA recognition by a novel cyclic aminoglycoside analogue.
Raghunathan D; Sánchez-Pedregal VM; Junker J; Schwiegk C; Kalesse M; Kirschning A; Carlomagno T
Nucleic Acids Res; 2006; 34(12):3599-608. PubMed ID: 16855296
[TBL] [Abstract][Full Text] [Related]
11. Similarity of the 5' and 3'-TAR secondary structures in HIV-1.
Wang P; Rouyez MC; Ducamp S; Saragosti S; Ventura M
Biochem Biophys Res Commun; 1993 Sep; 195(2):565-73. PubMed ID: 8373397
[TBL] [Abstract][Full Text] [Related]
12. Structures of HIV TAR RNA-ligand complexes reveal higher binding stoichiometries.
Ferner J; Suhartono M; Breitung S; Jonker HR; Hennig M; Wöhnert J; Göbel M; Schwalbe H
Chembiochem; 2009 Jun; 10(9):1490-4. PubMed ID: 19444830
[TBL] [Abstract][Full Text] [Related]
13. Role of the 5' TAR stem--loop and the U5-AUG duplex in dimerization of HIV-1 genomic RNA.
Song R; Kafaie J; Laughrea M
Biochemistry; 2008 Mar; 47(10):3283-93. PubMed ID: 18278873
[TBL] [Abstract][Full Text] [Related]
14. Cyclic PNA-based compound directed against HIV-1 TAR RNA: modelling, liquid-phase synthesis and TAR binding.
Depecker G; Patino N; Di Giorgio C; Terreux R; Cabrol-Bass D; Bailly C; Aubertin AM; Condom R
Org Biomol Chem; 2004 Jan; 2(1):74-9. PubMed ID: 14737662
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.
Mayer M; Lang PT; Gerber S; Madrid PB; Pinto IG; Guy RK; James TL
Chem Biol; 2006 Sep; 13(9):993-1000. PubMed ID: 16984889
[TBL] [Abstract][Full Text] [Related]
16. In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1.
Watrin M; Von Pelchrzim F; Dausse E; Schroeder R; Toulmé JJ
Biochemistry; 2009 Jul; 48(26):6278-84. PubMed ID: 19496624
[TBL] [Abstract][Full Text] [Related]
17. Inert benzothiazole functionalised ruthenium(II) complexes; potential DNA hairpin binding agents.
Spillane CB; Morgan JL; Fletcher NC; Collins JG; Keene FR
Dalton Trans; 2006 Jul; (25):3122-33. PubMed ID: 16786071
[TBL] [Abstract][Full Text] [Related]
18. Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.
Murchie AI; Davis B; Isel C; Afshar M; Drysdale MJ; Bower J; Potter AJ; Starkey ID; Swarbrick TM; Mirza S; Prescott CD; Vaglio P; Aboul-ela F; Karn J
J Mol Biol; 2004 Feb; 336(3):625-38. PubMed ID: 15095977
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic studies of mini-TAR RNA/DNA annealing in the absence and presence of HIV-1 nucleocapsid protein.
Vo MN; Barany G; Rouzina I; Musier-Forsyth K
J Mol Biol; 2006 Oct; 363(1):244-61. PubMed ID: 16962137
[TBL] [Abstract][Full Text] [Related]
20. Structural biology: the dance of domains.
Puglisi JD
Nature; 2007 Dec; 450(7173):1171-2. PubMed ID: 18097392
[No Abstract] [Full Text] [Related]
[Next] [New Search]
